By

Sara Dagen

Scientists Train AI To Illuminate Drugs’ Impact on Cellular Targets

An ideal medicine for one person may prove ineffective or harmful for someone else, and predicting who could benefit from a given drug has been difficult. Now, an international team led by neuroscientist Kirill Martemyanov, Ph.D., based at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, is training artificial intelligence to assist.

Tech Tuesday: A Helpful Virus

In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Dr. Arun Srivastava from the University of Florida's College of Medicine Department of Pediatrics who introduces us to a virus -- the adeno-associated virus or AAV -- that cures rather than infects. AAV has cured nine human diseases. The FDA has approved five drugs using it. And Dr. Srivastava's lab of scientists is working to make the vectors more efficient.

UF Health Cancer Center Hosts 3rd Annual AI Day

The UF Health Cancer Center hosted its 3rd Annual AI Day in Cancer Research, drawing speakers and attendees from a range of disciplines, such as engineering, public health, data science, and radiology, to learn more about the role of AI in cancer research.